Hood River Capital Management LLC Coherus Bio Sciences, Inc. Transaction History

Hood River Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $6.41 Million - $7.33 Million	-386,932 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $4.88 Million - $5.57 Million	-280,096 Reduced 41.99%	386,932 $7.1 Million
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $1 Million - $1.33 Million	-69,527 Reduced 9.44%	667,028 $11.9 Million
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $3.32 Million - $6.41 Million	-284,606 Reduced 27.87%	736,555 $11.9 Million
Q4 2019 Feb 13, 2020	SELL	$16.33 - $21.37 $265,329 - $347,219	-16,248 Reduced 1.57%	1,021,161 $18.4 Million
Q3 2019 Nov 13, 2019	BUY	$16.3 - $23.37 $4.41 Million - $6.32 Million	270,598 Added 35.29%	1,037,409 $21 Million
Q2 2019 Aug 13, 2019	BUY	$13.1 - $22.1 $10 Million - $16.9 Million	766,811 New	766,811 $16.9 Million

135

78M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $108M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Hood River Capital Management LLC with notifications on news.